<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411054/" ref="ordinalpos=526&amp;ncbi_uid=5161751&amp;link_uid=PMC3411054" image-link="/pmc/articles/PMC3411054/figure/F7/" class="imagepopup">FIGURE 7. From: Targeting the Sonic Hedgehog <span class="highlight" style="background-color:">Pathway</span> in Keratocystic Odontogenic Tumor. </a></div><br /><div class="p4l_captionBody"><b>Treatment of the KCOT-1 cells with cyclopamine down-regulated components of the NOTCH signaling pathway.</b> KCOT-1 cells treated with cyclopamine (10, 20, 25 μm) or tomatidine (5, 10 μm) for 48 h. A, protein expression of the NOTCH pathway with and without cyclopamine treatment. B, densitometric analysis of the calculated reduction of the protein levels of the NOTCH signaling pathway. C, gene expression of the NOTCH signaling pathway in KCOT-1 cells. Error bars indicate S.D. D, top and bottom, immunohistochemical detection of NOTCH-2, NOTCH-3, and JAG-2 in KCOT-1 cells (top) and tumor tissue (bottom).</div></div>